Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.
about
Developmental Dynamics of Rett SyndromeMeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background.Ectonucleotidase activity and immunosuppression in astrocyte-CD4 T cell bidirectional signaling.Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin associationStress and the Emerging Roles of Chromatin Remodeling in Signal Integration and Stable Transmission of Reversible Phenotypes.MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defectsCDKL5 localizes at the centrosome and midbody and is required for faithful cell division.MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett SyndromemGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome.Lack of Methyl-CpG Binding Protein 2 (MeCP2) Affects Cell Fate Refinement During Embryonic Cortical Development.Rett syndrome: a neurological disorder with metabolic components.Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental DisordersRegenerative glutamate release in the hippocampus of Rett syndrome model miceLack of the Actin Capping Protein, Eps8, Affects NMDA-Type Glutamate Receptor Function and Composition
P2860
Q26768284-5FFABC5C-FD92-452C-80CC-DB226611EEFAQ35995005-598C8B5C-A5E7-4248-A74B-0CE8B19D06B4Q36905624-388CDDD1-CCB8-462B-B05D-CDA5E83A0B69Q37024209-104EFC50-E4FD-4139-AC24-3384BE66AF00Q37699534-A7A8DA61-A793-4BF9-8D07-AA01CB32778AQ38821957-059B660A-BD46-4DC5-9C0F-00DB0F3D9B2BQ38873330-0C794A85-1674-4EAF-8D7B-1CA4BA827334Q41109322-22FE3218-646D-4690-9B73-2656BEF0457FQ42372796-065C4103-3A0E-4B56-81BF-D3FF83E49CC4Q47738098-DD890AA9-D0D8-4FE2-87EF-E83F9F54F6D1Q47851474-D4CDEEF8-4F8C-47F7-AED4-4B9C1746C932Q50422613-98C5F877-B570-4CD1-8FC3-D6525AAAC8B0Q58573091-9D29A01F-A786-4FEF-B0F9-043422435892Q58696176-7DF36C9C-D22C-4089-9B34-12A7AF94FCDAQ58763012-02219545-DB59-4040-955D-BEF41471466F
P2860
Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Defects During Mecp2 Null Embr ...... f Overt Neurological Symptoms.
@en
type
label
Defects During Mecp2 Null Embr ...... f Overt Neurological Symptoms.
@en
prefLabel
Defects During Mecp2 Null Embr ...... f Overt Neurological Symptoms.
@en
P2093
P2860
P50
P356
P1433
P1476
Defects During Mecp2 Null Embr ...... of Overt Neurological Symptoms
@en
P2093
Clementina Cobolli Gigli
Linda Scaramuzza
Riccardo Lorenzo Rossi
P2860
P304
P356
10.1093/CERCOR/BHV078
P50
P577
2015-05-15T00:00:00Z